NPS Pharmaceuticals Spikes 19% Amid Shire Bid Report

NPS Pharmaceuticals, Inc. NPSP soared 19 percent amid a Bloomberg report that Shire PLC (ADR) SHPG is considering a bid for the company.

NPS Pharmaceuticals recently traded at $36.24, up 19.3 percent.

Shortly after the news broke, Ian Estepan tweeted that others may also be targeted:

$SHPG also says that they are reviewing other targets - most logical other target $FOLD

— Ian Estepan (@ianestepan) December 17, 2014

Amicus Therapeutics, Inc. FOLD also popped amid the news and recently traded at $7.98, up 3.2 percent.

Shire recently traded at $212.10, up 1.6 percent.